# 9-valent HPV Vaccine in Postpartum Women

> **NCT04311528** · PHASE4 · UNKNOWN · sponsor: **Augusta University** · enrollment: 100 (estimated)

## Conditions studied

- Human Papilloma Virus

## Interventions

- **BIOLOGICAL:** 9-valent HPV vaccine

## Key facts

- **NCT ID:** NCT04311528
- **Lead sponsor:** Augusta University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04311528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04311528, "9-valent HPV Vaccine in Postpartum Women". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04311528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*